Cardioprotection from ischaemia-reperfusion injury by a novel flavonol that reduces activation of p38 MAPK

Thomas, C, Ng, D, Patsikatheodorou, N, Limengka, Y, Lee, M, Darby, I, Woodman, O and May, C 2011, 'Cardioprotection from ischaemia-reperfusion injury by a novel flavonol that reduces activation of p38 MAPK', European Journal of Pharmacology, vol. 658, no. 2Mar, pp. 160-167.

Document type: Journal Article
Collection: Journal Articles

Title Cardioprotection from ischaemia-reperfusion injury by a novel flavonol that reduces activation of p38 MAPK
Author(s) Thomas, C
Ng, D
Patsikatheodorou, N
Limengka, Y
Lee, M
Darby, I
Woodman, O
May, C
Year 2011
Journal name European Journal of Pharmacology
Volume number 658
Issue number 2Mar
Start page 160
End page 167
Total pages 8
Publisher Elsevier BV
Abstract Oxidative stress, activation of intracellular protein kinases and cardiomyocyte apoptosis are known mediators of cardiac ischaemia/reperfusion injury. The sites at which NP202, a novel water soluble pro-drug of 3',4'-dihydroxyflavonol (DiOHF), acts in this cascade to cause cardioprotection are unknown. In this study we examined the ability of NP202 to reduce infarct size after a prolonged period of ischaemia and reperfusion. In addition, we tested whether NP202 inhibits pro-apoptotic signalling, apoptosis and inflammation following myocardial ischaemia and reperfusion. Sheep were anaesthetised, the heart exposed and the 2nd branch of the left anterior descending coronary artery isolated. The artery was occluded for 3 h and, five minutes before 3 h of reperfusion was commenced, sheep were treated with intravenous vehicle or NP202. At the end of reperfusion infarct size was measured and normal left ventricle, non-infarcted area-at-risk and infarcted myocardium were collected to identify polymorphonuclear leukocytes (PMN) or apoptotic cells (TUNEL-positive), or assessed for activation of mitogen-activated protein kinase (MAPK) pathways by Western blot analysis. Compared with vehicle treatment, NP202 reduced infarct size (-20 +/- 4%, P < 0.05) and decreased the number of PMNs and TUNEL-positive cells in the area-at-risk (-35 +/- 16% and -52 +/- 19%, respectively) and infarcted tissue (-57 +/- 9 and 81 +/- 5%, respectively, P < 0.05). Furthermore, NP202 significantly reduced I/R-induced elevated p38 MAPK phosphorylation (by 67 4%, P < 0.05) in the area-at-risk zone. In conclusion, the novel aqueous flavonol NP202 provided significant cardioprotection from clinically relevant prolonged myocardial ischaemia when administered just before reperfusion. Efficacy of NP202 was also associated with reduced p38 MAPK activation, inflammation and apoptotic cell death. (C) 2011 Elsevier B.V. All rights reserved.
Subject Cardiology (incl. Cardiovascular Diseases)
Keyword(s) Antioxidant
Myocardial ischaemia-reperfusion injury
p38 MAPK
Survival kinases
DOI - identifier 10.1016/j.ejphar.2011.02.041
Copyright notice © 2011 Elsevier B.V.
ISSN 0014-2999
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 25 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 21 times in Scopus Article | Citations
Altmetric details:
Access Statistics: 189 Abstract Views  -  Detailed Statistics
Created: Fri, 07 Oct 2011, 08:50:00 EST by Catalyst Administrator
© 2014 RMIT Research Repository • Powered by Fez SoftwareContact us